CAROL CHUKWUKA: Open Payments
NPI 1174176093 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,380 in 76 payments from 13 companies in 2025. Trend: 2023 $475 · 2024 $665 · 2025 $1,380
Food & beverage: $1,380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $265 |
| Otsuka America Pharmaceutical, Inc. | 12 | $242 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $159 |
| Janssen Pharmaceuticals, Inc | 2 | $146 |
| Axsome Therapeutics, Inc. | 5 | $118 |
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
| Corium, LLC | 3 | $84 |
| Alkermes, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Lundbeck LLC | 3 | $51 |
Products named: VRAYLAR, REXULTI, CAPLYTA, SPRAVATO, Auvelity, Azstarys, AUSTEDO XR, COBENFY.
Industry payments across IA — which companies pay providers there.
